An update on applications and limitations of direct oral anticoagulants

An update on applications and limitations of direct oral anticoagulants

Abstract A major advancement in the field of medicine has been the introduction and usage of direct oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and rivaroxaban (Xarelto). DOACs have been increasing in popularity for mainstay anticoagulation pharmacotherapy and are b...

Full description

Bibliographic Details
Main Authors: Sharon Wei, Aanchal Sawhney, Harshwardhan Khandait, Amit Meda, Vasu Gupta, Rohit Jain
Format: Article
Language:English
Published: SpringerOpen 2023-04-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
DOACs
Apixaban
Nonvalvular atrial fibrillation
Rivaroxaban
Factor Xa
Warfarin
Online Access:https://doi.org/10.1186/s43162-023-00212-5

Internet

https://doi.org/10.1186/s43162-023-00212-5

Similar Items